Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Elizabeth McFarland

Concepts (388)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
52
2026
3158
3.140
 Why?
HIV-1
28
2026
897
2.900
 Why?
Respiratory Syncytial Virus Vaccines
6
2022
39
2.210
 Why?
HIV Antibodies
14
2026
61
2.210
 Why?
Respiratory Syncytial Virus Infections
6
2022
136
2.030
 Why?
Respiratory Syncytial Virus, Human
6
2022
81
2.010
 Why?
Infectious Disease Transmission, Vertical
18
2025
193
1.990
 Why?
Anti-HIV Agents
15
2026
890
1.730
 Why?
Anti-Retroviral Agents
12
2023
250
1.630
 Why?
Viral Proteins
3
2020
355
1.480
 Why?
Antibodies, Neutralizing
10
2026
342
1.110
 Why?
Antibodies, Viral
8
2022
673
1.060
 Why?
Antibodies, Monoclonal
7
2026
1525
0.950
 Why?
Colonography, Computed Tomographic
3
2024
8
0.920
 Why?
Pregnancy Complications, Infectious
9
2026
429
0.880
 Why?
HIV Protease Inhibitors
3
2026
69
0.820
 Why?
AIDS Vaccines
8
2018
53
0.810
 Why?
Pre-Exposure Prophylaxis
1
2025
247
0.750
 Why?
Gene Deletion
2
2020
389
0.690
 Why?
Breast Feeding
4
2025
448
0.610
 Why?
Atazanavir Sulfate
2
2017
42
0.600
 Why?
Ritonavir
2
2017
75
0.590
 Why?
Infant, Newborn
24
2026
6456
0.560
 Why?
HIV Envelope Protein gp120
6
2017
55
0.550
 Why?
Vaccination
6
2020
1428
0.550
 Why?
Vaccines, Attenuated
6
2022
129
0.550
 Why?
Incidental Findings
1
2018
80
0.520
 Why?
Infant
33
2026
10101
0.520
 Why?
Nelfinavir
1
2016
8
0.480
 Why?
Radiation Dosage
1
2018
193
0.480
 Why?
Telemedicine
1
2025
957
0.480
 Why?
Lopinavir
1
2016
30
0.470
 Why?
Syncope
1
2016
55
0.470
 Why?
Bradycardia
1
2016
59
0.460
 Why?
Patient Dropouts
1
2016
65
0.460
 Why?
Lyme Disease
1
2016
58
0.460
 Why?
Health Resources
1
2016
131
0.440
 Why?
Infant, Newborn, Diseases
1
2016
113
0.420
 Why?
HIV
5
2014
250
0.400
 Why?
Humans
78
2026
145305
0.380
 Why?
Patient Compliance
2
2018
589
0.380
 Why?
Child
38
2026
22712
0.370
 Why?
Female
52
2026
78605
0.370
 Why?
Immunogenicity, Vaccine
4
2021
36
0.360
 Why?
Referral and Consultation
1
2018
853
0.350
 Why?
T-Lymphocytes, Cytotoxic
4
2005
177
0.340
 Why?
CD4-Positive T-Lymphocytes
2
2017
1130
0.330
 Why?
Male
43
2026
72628
0.330
 Why?
Virus Replication
4
2020
529
0.330
 Why?
Adolescent
28
2025
22507
0.320
 Why?
Viral Load
10
2026
527
0.310
 Why?
Lymphocyte Activation
5
2017
1127
0.300
 Why?
Young Adult
14
2026
14163
0.280
 Why?
HIV Seropositivity
2
2023
119
0.260
 Why?
DNA, Viral
3
2026
358
0.260
 Why?
Bone Density
2
2025
482
0.260
 Why?
Double-Blind Method
3
2020
2033
0.250
 Why?
RNA, Viral
8
2023
688
0.240
 Why?
Antibodies, Bacterial
2
2018
148
0.230
 Why?
Antiretroviral Therapy, Highly Active
6
2017
278
0.220
 Why?
Dyslipidemias
2
2017
182
0.220
 Why?
Bone Development
1
2025
52
0.220
 Why?
Prenatal Exposure Delayed Effects
2
2026
675
0.220
 Why?
Puberty
1
2026
140
0.210
 Why?
Immunoenzyme Techniques
1
2005
200
0.210
 Why?
Pregnancy
12
2026
7208
0.210
 Why?
Immunoglobulin G
3
2022
893
0.210
 Why?
Diverticulum
1
2024
14
0.200
 Why?
Viremia
3
2011
158
0.200
 Why?
Gene Products, gag
2
1994
38
0.200
 Why?
Mammography
1
2025
166
0.200
 Why?
Child, Preschool
21
2022
11863
0.190
 Why?
Squalene
3
2017
8
0.190
 Why?
Complementarity Determining Regions
1
2002
53
0.180
 Why?
Prospective Studies
5
2025
8011
0.180
 Why?
Drug Resistance, Viral
2
2016
123
0.180
 Why?
CD4 Lymphocyte Count
4
2017
278
0.180
 Why?
Growth Differentiation Factor 15
1
2021
41
0.170
 Why?
Half-Life
1
2021
153
0.170
 Why?
Feasibility Studies
1
2025
1103
0.170
 Why?
Immunization Schedule
2
2018
188
0.170
 Why?
Mitochondrial Diseases
1
2021
93
0.170
 Why?
Colorado
4
2025
4579
0.170
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
331
0.160
 Why?
T-Lymphocytes
2
2009
1984
0.160
 Why?
Drug Therapy, Combination
4
2017
1048
0.160
 Why?
RNA, Small Untranslated
1
2020
14
0.160
 Why?
Fibroblast Growth Factors
1
2021
188
0.160
 Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.160
 Why?
Pilot Projects
1
2025
1894
0.150
 Why?
Hydrophobic and Hydrophilic Interactions
1
2020
192
0.150
 Why?
Cytokines
2
2021
2066
0.150
 Why?
Point Mutation
1
2020
243
0.140
 Why?
Body Temperature
1
2020
229
0.140
 Why?
Immunocompromised Host
2
2000
201
0.140
 Why?
Haemophilus Vaccines
2
2018
29
0.140
 Why?
Insulin Resistance
3
2019
1243
0.140
 Why?
Immunologic Memory
2
2021
366
0.140
 Why?
Interleukin-12
1
1998
117
0.130
 Why?
Darunavir
1
2017
20
0.130
 Why?
Metabolic Syndrome
1
2021
356
0.130
 Why?
CD8-Positive T-Lymphocytes
2
2011
918
0.130
 Why?
Mycobacterium Infections, Nontuberculous
2
2012
368
0.130
 Why?
Dose-Response Relationship, Drug
1
2021
2032
0.130
 Why?
Therapeutic Equipoise
1
2017
2
0.130
 Why?
Interferon-gamma
5
2012
784
0.130
 Why?
Antibody Formation
1
2018
294
0.130
 Why?
Lymphopoiesis
1
2017
27
0.130
 Why?
Immunoglobulin A
2
2017
214
0.130
 Why?
Uganda
1
2017
93
0.120
 Why?
Receptors, CCR5
1
2017
60
0.120
 Why?
CD4-CD8 Ratio
1
2016
23
0.120
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.120
 Why?
High-Throughput Screening Assays
1
2018
175
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Mothers
3
2017
776
0.120
 Why?
Adult
16
2026
40627
0.120
 Why?
Virus Latency
1
2016
90
0.120
 Why?
Cohort Studies
8
2025
5982
0.120
 Why?
Early Diagnosis
1
2016
249
0.110
 Why?
Chickenpox Vaccine
1
2015
75
0.110
 Why?
Continuity of Patient Care
1
2018
293
0.110
 Why?
Disease Susceptibility
1
2017
348
0.110
 Why?
Zimbabwe
2
2025
76
0.110
 Why?
Gene Products, env
1
1994
7
0.110
 Why?
Body Height
2
2017
202
0.110
 Why?
Chickenpox
1
2015
81
0.110
 Why?
Haemophilus influenzae type b
1
2014
12
0.110
 Why?
Bacterial Capsules
1
2014
33
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Acquired Immunodeficiency Syndrome
2
2000
235
0.110
 Why?
Cote d'Ivoire
2
2025
8
0.100
 Why?
Parotitis
1
2014
6
0.100
 Why?
Vaccines, Synthetic
4
2005
138
0.100
 Why?
South Africa
2
2025
265
0.100
 Why?
Developing Countries
1
2016
319
0.100
 Why?
Cytotoxicity, Immunologic
3
2002
223
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Intestines
1
2017
358
0.100
 Why?
Leukocytes, Mononuclear
4
2013
573
0.100
 Why?
Vaccines
1
2018
390
0.100
 Why?
RNA-Directed DNA Polymerase
1
1993
35
0.100
 Why?
Mycobacterium chelonae
1
1993
8
0.100
 Why?
Injections, Subcutaneous
2
2026
164
0.100
 Why?
Patient Selection
1
2017
726
0.090
 Why?
Lamivudine
3
2023
65
0.090
 Why?
Lipids
1
2017
712
0.090
 Why?
Retrospective Studies
8
2023
17149
0.090
 Why?
Colorectal Neoplasms
1
2020
849
0.090
 Why?
Cell Movement
1
2017
965
0.090
 Why?
Mitochondria
2
2021
987
0.090
 Why?
Breast Neoplasms
1
2025
2464
0.090
 Why?
STAT1 Transcription Factor
1
2012
68
0.090
 Why?
Cardiovascular Diseases
2
2016
2182
0.090
 Why?
Child Development
1
2017
490
0.090
 Why?
Body Fat Distribution
1
2011
45
0.090
 Why?
Body Weight
2
2017
980
0.090
 Why?
Pediatric Obesity
1
2019
645
0.090
 Why?
Clinical Trials as Topic
1
2017
1063
0.090
 Why?
Polysorbates
3
2017
42
0.090
 Why?
Mycobacterium avium Complex
1
2012
88
0.080
 Why?
Epitopes
2
2022
485
0.080
 Why?
Cost-Benefit Analysis
2
2025
639
0.080
 Why?
Research Design
1
2017
1137
0.080
 Why?
United States
9
2023
16051
0.080
 Why?
Biomedical Research
1
2017
713
0.080
 Why?
Interleukin-2
2
2003
437
0.080
 Why?
Respiratory Tract Infections
1
2014
399
0.070
 Why?
Freezing
1
2009
86
0.070
 Why?
Exercise
1
2021
2206
0.070
 Why?
Absorptiometry, Photon
2
2025
276
0.070
 Why?
Blood
1
2009
109
0.070
 Why?
Phenotype
1
2017
3172
0.070
 Why?
Algorithms
1
2016
1846
0.070
 Why?
Age Factors
4
2019
3339
0.070
 Why?
T-Lymphocyte Subsets
2
2002
415
0.070
 Why?
Staff Development
1
2009
65
0.070
 Why?
Lymphocyte Subsets
2
2009
83
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2021
851
0.070
 Why?
Biomarkers
4
2021
4284
0.070
 Why?
Longitudinal Studies
3
2025
2959
0.070
 Why?
Enterovirus A, Human
1
2007
13
0.070
 Why?
Specimen Handling
1
2009
186
0.070
 Why?
Faculty
1
2009
153
0.070
 Why?
Withholding Treatment
1
2008
81
0.060
 Why?
Adipose Tissue
1
2011
653
0.060
 Why?
Central Nervous System Viral Diseases
1
2007
78
0.060
 Why?
Polymerase Chain Reaction
4
2011
1054
0.060
 Why?
Flow Cytometry
3
2009
1173
0.060
 Why?
Academic Medical Centers
1
2009
548
0.060
 Why?
Monte Carlo Method
1
2026
155
0.060
 Why?
False Negative Reactions
1
2025
61
0.060
 Why?
Enterovirus Infections
1
2007
173
0.050
 Why?
Cell Line
3
2012
2882
0.050
 Why?
Isoantigens
1
1984
17
0.050
 Why?
C-Reactive Protein
2
2021
420
0.050
 Why?
Medical Audit
1
2025
77
0.050
 Why?
Immunity, Cellular
1
2006
273
0.050
 Why?
Linear Models
2
2020
854
0.050
 Why?
Disease Outbreaks
1
2007
422
0.050
 Why?
Follow-Up Studies
3
2021
5431
0.050
 Why?
Confusion
1
2024
30
0.050
 Why?
Comorbidity
2
2021
1661
0.050
 Why?
Sequence Analysis, DNA
2
2007
824
0.050
 Why?
Thymus Gland
1
1984
311
0.050
 Why?
Tablets
1
2023
41
0.050
 Why?
Constriction, Pathologic
1
2024
248
0.050
 Why?
Regression Analysis
2
2021
1003
0.050
 Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.050
 Why?
Risk Factors
4
2021
10816
0.050
 Why?
Immunophenotyping
2
1994
322
0.050
 Why?
Zidovudine
2
2015
77
0.050
 Why?
Clone Cells
1
2002
266
0.040
 Why?
Dose-Response Relationship, Immunologic
1
2001
76
0.040
 Why?
Cough
1
2022
124
0.040
 Why?
Emtricitabine
1
2023
205
0.040
 Why?
Triazoles
1
2023
184
0.040
 Why?
Vaccines, Subunit
1
2001
53
0.040
 Why?
Pyridones
1
2023
200
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2021
52
0.040
 Why?
Ganciclovir
1
2000
53
0.040
 Why?
Tenofovir
1
2023
295
0.040
 Why?
Public Health Surveillance
1
2021
83
0.040
 Why?
Lung
1
2014
4112
0.040
 Why?
Computer Simulation
1
2005
1026
0.040
 Why?
Africa
1
2020
117
0.040
 Why?
Adjuvants, Immunologic
2
2017
246
0.040
 Why?
Diagnostic Tests, Routine
1
2021
108
0.040
 Why?
Symptom Assessment
1
2021
137
0.040
 Why?
Sex Factors
2
2019
2115
0.040
 Why?
HIV Seronegativity
1
2019
29
0.040
 Why?
Cross-Sectional Studies
3
2021
5883
0.040
 Why?
HLA-D Antigens
1
1999
30
0.040
 Why?
Risk
1
2021
912
0.040
 Why?
Case-Control Studies
2
2019
3613
0.040
 Why?
Cytomegalovirus Infections
1
2000
206
0.040
 Why?
Lymphocyte Culture Test, Mixed
1
1998
51
0.040
 Why?
Cytotoxicity Tests, Immunologic
1
1998
37
0.040
 Why?
Cholesterol, HDL
1
2019
200
0.040
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
28
0.040
 Why?
Prevalence
2
2016
2838
0.040
 Why?
Vaccines, Combined
1
2018
49
0.040
 Why?
Hospitals
1
2023
733
0.030
 Why?
Poliovirus Vaccine, Inactivated
1
2018
27
0.030
 Why?
Amino Acid Sequence
1
2002
2158
0.030
 Why?
Odds Ratio
1
2021
1077
0.030
 Why?
Hepatitis B Vaccines
1
2018
43
0.030
 Why?
Mutation
3
2018
4104
0.030
 Why?
Drug Resistance, Microbial
2
2000
70
0.030
 Why?
Molecular Sequence Data
1
2002
2931
0.030
 Why?
Colon
1
2020
305
0.030
 Why?
Nutrition Surveys
1
2019
282
0.030
 Why?
Case Management
1
2018
68
0.030
 Why?
Antigens, Viral
1
1998
182
0.030
 Why?
Cholesterol, LDL
1
2019
359
0.030
 Why?
Cholesterol
1
2019
408
0.030
 Why?
Epitopes, T-Lymphocyte
1
1998
175
0.030
 Why?
Treatment Adherence and Compliance
1
2017
27
0.030
 Why?
Immune Tolerance
1
1999
379
0.030
 Why?
Triglycerides
1
2019
521
0.030
 Why?
Disease Management
1
2021
647
0.030
 Why?
Reproducibility of Results
1
2005
3419
0.030
 Why?
Cell Division
1
1998
766
0.030
 Why?
Lymphocyte Count
2
2009
164
0.030
 Why?
Uncertainty
1
2017
145
0.030
 Why?
Treatment Failure
1
2017
365
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Multicenter Studies as Topic
1
2017
411
0.030
 Why?
Seroepidemiologic Studies
1
2015
173
0.030
 Why?
Patient Outcome Assessment
1
2016
134
0.030
 Why?
Genes, pol
1
1994
7
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Maternal Exposure
1
2017
213
0.030
 Why?
Antiviral Agents
1
2000
768
0.030
 Why?
Time-to-Treatment
1
2017
245
0.030
 Why?
Vaccines, Conjugate
1
2014
60
0.030
 Why?
Coinfection
1
2016
142
0.030
 Why?
Counseling
1
2018
409
0.030
 Why?
Neutropenia
1
2015
155
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1747
0.030
 Why?
Treatment Outcome
2
2021
11731
0.030
 Why?
Cells, Cultured
2
2008
4155
0.030
 Why?
Global Health
1
2017
403
0.020
 Why?
Sexual and Gender Minorities
1
2018
251
0.020
 Why?
Anemia
1
2015
189
0.020
 Why?
Maternal-Fetal Exchange
1
2014
169
0.020
 Why?
Electron Transport Complex IV
1
2013
62
0.020
 Why?
Electron Transport Complex I
1
2013
42
0.020
 Why?
Thrombocytopenia
1
2015
205
0.020
 Why?
Tuberculosis, Cutaneous
1
1993
2
0.020
 Why?
HIV Reverse Transcriptase
1
1993
31
0.020
 Why?
CD8 Antigens
1
1993
72
0.020
 Why?
Radiography, Thoracic
1
2014
171
0.020
 Why?
Severity of Illness Index
1
2021
2926
0.020
 Why?
Medication Adherence
1
2017
541
0.020
 Why?
CD3 Complex
1
1993
111
0.020
 Why?
Drug Administration Schedule
2
2008
783
0.020
 Why?
Lymphocytes
1
1994
382
0.020
 Why?
Blood Pressure
1
2019
1771
0.020
 Why?
Oxidative Phosphorylation
1
2013
210
0.020
 Why?
DNA, Mitochondrial
1
2013
212
0.020
 Why?
P-Selectin
1
2011
28
0.020
 Why?
E-Selectin
1
2011
61
0.020
 Why?
Heteroduplex Analysis
1
2011
1
0.020
 Why?
Tuberculosis, Pulmonary
1
1993
131
0.020
 Why?
Pandemics
1
2020
1698
0.020
 Why?
Chemokine CCL2
1
2011
117
0.020
 Why?
Antigens, CD
1
1994
555
0.020
 Why?
Blood Transfusion
1
1994
405
0.020
 Why?
Cell Proliferation
2
2009
2506
0.020
 Why?
Hyperlipidemias
1
2011
122
0.020
 Why?
Interferon-alpha
1
2012
197
0.020
 Why?
Protein Multimerization
1
2012
214
0.020
 Why?
Fibrinogen
1
2011
179
0.020
 Why?
Cell Adhesion Molecules
1
2011
178
0.020
 Why?
Nontuberculous Mycobacteria
1
1993
210
0.020
 Why?
Hospitalization
1
2021
2443
0.020
 Why?
Cross Infection
1
1993
263
0.020
 Why?
Infant, Premature
1
1994
611
0.020
 Why?
Healthcare Disparities
1
2017
736
0.020
 Why?
Diagnosis, Differential
1
2014
1500
0.020
 Why?
Pokeweed Mitogens
1
2009
7
0.020
 Why?
L-Selectin
1
2009
27
0.020
 Why?
Human Experimentation
1
2009
12
0.020
 Why?
Tetanus
1
2009
26
0.020
 Why?
Candida
1
2009
44
0.020
 Why?
Leukocyte Common Antigens
1
2009
90
0.020
 Why?
Multivariate Analysis
1
2011
1540
0.020
 Why?
Obesity
1
2021
3085
0.020
 Why?
Meningitis, Aseptic
1
2007
13
0.020
 Why?
Virus Cultivation
1
2007
31
0.020
 Why?
Phosphorylation
1
2012
1735
0.020
 Why?
Interleukin-6
1
2011
782
0.020
 Why?
Cerebrospinal Fluid
1
2007
88
0.020
 Why?
Data Interpretation, Statistical
1
2009
372
0.020
 Why?
Paralysis
1
2007
67
0.020
 Why?
Multiple Organ Failure
1
2007
124
0.020
 Why?
Pregnancy Outcome
1
2010
480
0.020
 Why?
B-Lymphocytes
1
2012
877
0.020
 Why?
Kinetics
1
2010
1630
0.010
 Why?
Genotype
1
2011
1845
0.010
 Why?
Respiratory System
1
2007
149
0.010
 Why?
Immunoglobulin A, Secretory
1
2005
8
0.010
 Why?
Cell Survival
1
2009
1099
0.010
 Why?
Phosphates
1
1987
180
0.010
 Why?
Muscles
1
1987
333
0.010
 Why?
Encephalitis
1
2007
142
0.010
 Why?
Mucous Membrane
1
2005
128
0.010
 Why?
Gastrointestinal Tract
1
2007
208
0.010
 Why?
Chemistry, Physical
1
1984
39
0.010
 Why?
Antigen-Antibody Reactions
1
1984
50
0.010
 Why?
Chemical Phenomena
1
1984
81
0.010
 Why?
Myasthenia Gravis
1
1984
24
0.010
 Why?
DNA-Binding Proteins
1
2012
1503
0.010
 Why?
Immunologic Deficiency Syndromes
1
1984
66
0.010
 Why?
Tissue Distribution
1
1984
334
0.010
 Why?
Saliva
1
2005
249
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2745
0.010
 Why?
Epithelium
1
1984
314
0.010
 Why?
Blood Glucose
1
2013
2333
0.010
 Why?
Aging
2
2003
1968
0.010
 Why?
Body Mass Index
1
2011
2439
0.010
 Why?
Infusions, Intravenous
1
2003
423
0.010
 Why?
Middle Aged
2
2020
36021
0.010
 Why?
Reference Values
1
2003
798
0.010
 Why?
Anti-Bacterial Agents
1
1993
1922
0.010
 Why?
Mice, Inbred BALB C
1
1984
1253
0.010
 Why?
Suspensions
1
2000
29
0.010
 Why?
Capsules
1
2000
43
0.010
 Why?
Drug Tolerance
1
2000
100
0.010
 Why?
Urban Population
1
2003
495
0.010
 Why?
Cytomegalovirus
1
2000
168
0.010
 Why?
Signal Transduction
1
2012
5239
0.010
 Why?
Administration, Oral
1
2000
848
0.010
 Why?
Immunization
1
2000
374
0.010
 Why?
Epithelial Cells
1
1984
1126
0.010
 Why?
Time Factors
1
2008
7186
0.010
 Why?
Recombinant Proteins
1
2000
1371
0.010
 Why?
Macrophages
1
1984
1514
0.010
 Why?
Tail
1
1987
29
0.000
 Why?
Phosphocreatine
1
1987
44
0.000
 Why?
Salamandridae
1
1987
33
0.000
 Why?
Mice
1
1984
18394
0.000
 Why?
Animals
2
1987
38177
0.000
 Why?
Aged
1
1984
26001
0.000
 Why?
Adenosine Triphosphate
1
1987
505
0.000
 Why?
Magnetic Resonance Spectroscopy
1
1987
631
0.000
 Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (388) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)